Summary
  • Multi-target molecules 315
  • Clinical molecules 0
  • Avg pChEMBL 7.76
Top Co-occurrence Targets
Active Molecules (315)
InChIKey pChEMBL Type Targets Clinical
KNQHCQDUNTWSPH 8.6 IC50 4
QAKOEUGWCNOHLP 8.6 IC50 4
RKNUBJJELTYQOF 8.6 IC50 4
SJNFJPFMHJLWNR 8.6 IC50 4
VNMXHBWOMGLDIH 8.6 IC50 4
DDZDRJQCCJHSJH 8.6 IC50 4
NALMWEJTNBTGFK 8.6 IC50 4
CFMGTKRBVVZVBF 8.5 IC50 4
HGMYODZJZPUWRC 8.5 IC50 4
HPKSTJTTXUFYNM 8.5 IC50 4
HQLIOGBJINMZFY 8.5 IC50 4
IQGJMNCUACIRBB 8.5 IC50 4
IWLXLASMFWNYHL 8.5 IC50 4
OALAYFQOTXVKEU 8.5 IC50 4
SSFQPBNIKXPGCC 8.5 IC50 4
ZZDPVPHOHNYTAU 8.5 IC50 4
BMBDQEBZOWGMBB 8.5 IC50 3
RWXBAQMWNLSEBP 8.5 IC50 4
CTSWGNQIQFMNNJ 8.5 IC50 4
KCVVJXPLYSFXRJ 8.5 IC50 4
NJWQXXNLNZOZAW 8.5 IC50 4
RDHZGKIYONRFGL 8.5 IC50 4
RWXBAQMWNLSEBP 8.5 IC50 4
SJNFJPFMHJLWNR 8.5 IC50 4
XEPCTFXTGPAHEJ 8.5 IC50 4
CFGJXJWENUPGMZ 8.4 IC50 4
RTDZYXVTDSBNJN 8.4 IC50 4
YTOCFEHRXHCGHM 8.4 IC50 3
IAWKVVNKOOMFDE 8.4 IC50 4
GGDBDVHXMMLBAO 8.3 IC50 4
HBNQFHFXMNHZLQ 8.3 IC50 4
IQKDRVURUHCSRA 8.3 IC50 4
NLCBQIDOYIYGHS 8.3 IC50 4
PSDGVCIVPCWWSM 8.3 IC50 4
RDKJPYDNPLIEFF 8.3 IC50 4
RTBFYUQKYCYIGP 8.3 IC50 4
XEPCTFXTGPAHEJ 8.3 IC50 4
ZHBIJTQYLJKLSK 8.3 IC50 4
IQGJMNCUACIRBB 8.3 IC50 4
MNXHOJWLGYZRKA 8.3 IC50 4
PEKAQWWCKOVJKE 8.3 IC50 4
QQHOKOMVWUCLCK 8.3 IC50 4
HLTMRTSTPMZYCW 8.3 IC50 4
ZEFCOSFYRNZVCT 8.3 IC50 4
INSJPGRKOSFBIE 8.2 IC50 3
BINCDYYXLHADFN 8.2 IC50 4
DLIOXULQASTBNO 8.2 IC50 4
DZNUXAJQSLZVLM 8.2 IC50 4
NNTCLBUNHKJZRJ 8.2 IC50 4
UKCYEDWUCSUQHI 8.2 Ki 2
2D structure